相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis
Karma Rabgay et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2020)
Opioids for chronic non-cancer neuropathic pain. An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration
Claudia Sommer et al.
EUROPEAN JOURNAL OF PAIN (2020)
Analgesic Effects of Cannabinoids for Chronic Non-cancer Pain: a Systematic Review and Meta-Analysis with Meta-Regression
Stanley Sau Ching Wong et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2020)
A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain
Michael A. Ueberall
JOURNAL OF PAIN RESEARCH (2020)
Guideline diagnosis and non interventional therapy of neuropathic pain of the German Society of Neurology (deutsche Gesellschaft fur Neurologie)
Tanja Schlereth
NEUROLOGICAL RESEARCH AND PRACTICE (2020)
Cannabinoids in Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis
Herman Johal et al.
CLINICAL MEDICINE INSIGHTS-ARTHRITIS AND MUSCULOSKELETAL DISORDERS (2020)
Sativex® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
Jolana Markova et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2019)
Effects of Cannabinoid Administration for Pain: A Meta-Analysis and Meta-Regression
Julio A. Yanes et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2019)
Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry
Michael A. Ueberall et al.
JOURNAL OF PAIN RESEARCH (2019)
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews
W. Haeuser et al.
EUROPEAN JOURNAL OF PAIN (2018)
The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report
Donald I. Abrams
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain
Aron H. Lichtman et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2018)
Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies
Emily Stockings et al.
PAIN (2018)
European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management
Winfried Haeuser et al.
EUROPEAN JOURNAL OF PAIN (2018)
Cannabinoids: from pot to lab
Esther Papaseit et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2018)
Opioids for Chronic Noncancer Pain A Systematic Review and Meta-analysis
Jason W. Busse et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Cannabinoids and Pain: New Insights From Old Molecules
Sonja Vuckovic et al.
FRONTIERS IN PHARMACOLOGY (2018)
Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis A Systematic Review and Meta-analysis
Mari Carmen Torres-Moreno et al.
JAMA NETWORK OPEN (2018)
An overview of treatment approaches for chronic pain management
Nicholas Hylands-White et al.
RHEUMATOLOGY INTERNATIONAL (2017)
The cannabinoid system and pain
Stephen G. Woodhams et al.
NEUROPHARMACOLOGY (2017)
Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis
Howard Meng et al.
ANESTHESIA AND ANALGESIA (2017)
Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies
Marie T. Fallon et al.
BRITISH JOURNAL OF PAIN (2017)
Are cannabinoids an effective treatment for chronic non-cancer pain?
Ruben F. Allende-Salazar et al.
MEDWAVE (2017)
Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain. A systematic review of randomized controlled studies
F. Petzke et al.
SCHMERZ (2016)
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
Penny F. Whiting et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials
M. E. Lynch et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
Neuropathic Pain: Principles of Diagnosis and Treatment
Ian Gilron et al.
MAYO CLINIC PROCEEDINGS (2015)
A classification of chronic pain for ICD-11
Rolf-Detlef Treede et al.
PAIN (2015)
The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuropathic Pain: A Systematic Review
Darrell G. Boychuk et al.
JOURNAL OF ORAL & FACIAL PAIN AND HEADACHE (2015)
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK
David J. Potter
DRUG TESTING AND ANALYSIS (2014)
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment
M. Serpell et al.
EUROPEAN JOURNAL OF PAIN (2014)
A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain
Mary E. Lynch et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2014)
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
R. M. Langford et al.
JOURNAL OF NEUROLOGY (2013)
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
Russell K. Portenoy et al.
JOURNAL OF PAIN (2012)
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials
Mary E. Lynch et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
A. Novotna et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Randomized Placebo-Controlled Double-Blind Clinical Trial of Cannabis-Based Medicinal Product (Sativex) in Painful Diabetic Neuropathy Depression is a major confounding factor
Dinesh Selvarajah et al.
DIABETES CARE (2010)
Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
Jeremy R. Johnson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
C. Collin et al.
NEUROLOGICAL RESEARCH (2010)
The Endocannabinoid System and Pain
Josee Guindon et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial
Turo J. Nurmikko et al.
PAIN (2007)
Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis
C. Collin et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
Michael Iskedjian et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Human cannabinoid pharmacokinetics
Marilyn A. Huestis
CHEMISTRY & BIODIVERSITY (2007)
painDETECT:: a new screening questionnaire to identify neuropathic components in patients with back pain
Rainer Freynhagen et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
E Russo et al.
MEDICAL HYPOTHESES (2006)
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
DR Blake et al.
RHEUMATOLOGY (2006)
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
DJ Rog et al.
NEUROLOGY (2005)
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial
JS Berman et al.
PAIN (2004)
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients
DT Wade et al.
MULTIPLE SCLEROSIS (2004)
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
DT Wade et al.
CLINICAL REHABILITATION (2003)
分享论文
